Development and preliminary application of a simple assay of S-mephenytoin 4-hydroxylase activity in human liver microsomes
- 1 July 1993
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 44 (6) , 559-562
- https://doi.org/10.1007/bf02440859
Abstract
Summary We have developed a simple HPLC assay to measure the activity of S-mephenytoin 4-hydroxylase in human liver microsomes, and have assessed its practical applicability by determining the kinetic parameters of the enzyme in 10 different human liver samples. The recovery of 4-hydroxymephenytoin and phenobarbital (the internal standard) after the precipitation of microsomal protein was almost complete, and the coefficients of variation for the intra-and interassay measurement of S-mephenytoin 4-hydroxylase activity were <6.4 and 8.0%, respectively. Eadie-Hofstee plots for the formation of 4-hydroxymephenytoin gave a straight line for all of the 10 samples studied. There was large interindividual variability in the kinetic parameters estimated: 4.6- (36 to 166 μM), 11.8- (0.9 to 10.6 nmole/mg protein/h) and 30.1-times (0.10 to 3.01 μl/mg protein/min) for Km, Vmax and Vmax/Km, respectively. The mean (±SD) Km, Vmax and Vmax/Km were 72.4±40.4 μM, 4.23±2.88 nmole/mg protein/h and 1.33±1.02 μl/mg protein/min, respectively. Thus, the assay was sufficiently accurate and reproducible to permit estimation of the kinetic parameters of S-mephenytoin 4-hydroxylase in human liver microsomes, and it appears to be applicable to an in vitro study of the possible involvement of S-mephenytoin-type oxidation polymorphism in drug metabolism.Keywords
This publication has 14 references indexed in Scilit:
- Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokineticsClinical Pharmacology & Therapeutics, 1992
- Polymorphism in hydroxylation of mephenytoin and hexobarbital stereoisomers in relation to hepatic P-450 human-2Clinical Pharmacology & Therapeutics, 1990
- Recent Developments in Hepatic Drug OxidationClinical Pharmacokinetics, 1990
- Genetic polymorphism of S-mephenytoin hydroxylationPharmacology & Therapeutics, 1989
- Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland ChineseClinical Pharmacology & Therapeutics, 1989
- Importance of genetic factors in the regulation of diazepam metabolism: Relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotypeClinical Pharmacology & Therapeutics, 1989
- Human drug metabolism in vitroPharmacology & Therapeutics, 1988
- Assay of mephenytoin metabolism in human liver microsomes by high-performance liquid chromatographyAnalytical Biochemistry, 1985
- Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in manEuropean Journal of Clinical Pharmacology, 1984
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951